0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Specialty Active Pharmaceutical Ingredients (API) Market Research Report 2020
Published Date: April 2020
|
Report Code: QYRE-Othe-2F261
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
specialty active pharmaceutical ingredients market

Global Specialty Active Pharmaceutical Ingredients (API) Market Research Report 2020

Code: QYRE-Othe-2F261
Report
April 2020
142 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
SPECIALTY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET OVERVIEW:

 

Active Pharmaceutical Ingredients (API) is a key link in pharmaceutical production and closely related to public health. And the Special API is different from the bulk API, has the characteristics of strong growth attribute, high customer stickiness, non-standard and so on, usually the gross profit rate and the net profit rate are high. Once the enterprise occupies a higher share in the dominant variety market, it can enjoy long-term stable profits.

Special APIs are components of chemical APIs. Chemical API companies generally produce and sell products independently or according to the needs of downstream customers.Its market is large and its customers are usually pharmaceutical preparation manufacturers, health products manufacturers, feed manufacturers and food manufacturers.

Featured API usually refers to the drug under patent protection or the drug under patent protection. If the enterprise can in innovative drug development stage and the original drug firms through customization methods such as establish relations of cooperation, to provide the clinical trials needed for active pharmaceutical ingredients, then after the product, the enterprise can to provide the original manufacturer pharmaceutical intermediates or APIs, usually can get stable orders, lasting profits for the enterprise. For drugs that have passed the patent period, take the export to the us market as an example, the API manufacturers usually pass the FDA certification before the patent drug expires, apply for the DMF filing, and carry out production capacity reserve. The customers also inform the API manufacturers to prepare the products in time. Generally, after the expiration of patented drugs, a large number of generic drugs will come to market, and drug prices will fall, which will increase the sales volume of generic drugs, and thus drive the demand for API drugs.

The main levels of Statins API are divided into Statins API, Heparin API and others such as Sartans API according to different fields.

Statins, with their high efficiency, safety and tolerability in lowering LDL and cholesterol, are in an unassailable position compared with other lipid-lowering drugs such as niacin and betts, with a market share of up to 90%.

Heparin API is in the middle of the heparin industry chain.First, the crude heparin sodium was extracted from the small intestinal mucosa of healthy pigs and made into heparin. Due to the impurities such as miscellaneous proteins, it was further purified and turned into heparin API.Heparin APIs are commonly found in the form of Sodium or Calcium salts, known as Heparin Sodium or Heparin Calcium, and are used in excess of standard Heparin Sodium.

 

The major Statins APIs player in the market

  • Livzon Pharmaceutical Group
  • Zhejiang Medicine
  • Zhejiang Hisun Pharmaceutical
  • Chongqing Daxin Pharmaceutical
  • Jiangsu Guotai International Group

 

In addition to the mainstream Statins APIs of various manufacturers, each manufacturer also has different models and functions of Heparin API

The major Heparin API player in the market

  • Changzhou Qianhong Biopharmal
  • Shenzhen Hepalink Pharmaceutical Group
  • CSBIO
  • Nanjing King-friend Biochemical Pharmaceutical

Heparin API belongs to Special API (different from bulk API). Heparin APIs are mainly used in the production of standard heparin preparations or low molecular weight heparin APIs, which can be further used in the production of low molecular weight heparin preparations.

In addition to the companies listed in the above table, Huahai Pharmaceutical, Apeloa Pharmaceutical, Borui Medicine, Jiuzhou Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Xianju Pharmaceutical, Zhejiang Starry Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Ausun Pharmaceutical, Jiangxi Synergy Pharmaceutical, Jiangxi Fushine Pharmaceutical, developed and manufacture Statins API.

According to the statistics of the medical insurance chamber of commerce, in 2018, China exported 929.72 tons of western medicine API (synthesis + fermentation), with a total export value of us $30.048 billion, accounting for about 19% of the global API market. outlines the location of manufacturing facilities used to make APIs for US-marketed drugs. For all regulated drugs (prescription [branded and generics], OTC products, and compounded drugs, the US has 510 manufacturing facilities or 28%, the rest of the world (non-China) 1,048 facilities, or 59%, and China 230 facilities or 13%.

 Specialty Active Pharmaceutical Ingredients (API ) Manufacturing

With the optimization of statin API production process and the formation of industrial scale in China, the capacity and output of statin API have been objectively promoted. With COVID-19 spreading globally, Europe and the United States have suffered a major impact. Meanwhile, COVID-19 affect major API suppliers such as India, China and Japan.

On March 24, India announced the start of a nationwide lockdown for 21 days as a precaution against COVID 19. But when India announced its decision, the global drug industry was not calm - after all, India is the world's largest producer of generic drugs, the 13th largest exporter by value and the third largest exporter by volume, which is crucial to the world's drug supply.

Global Special API Market Share

Under the influence of the global COVID 19 epidemic, China's API products ushered in a wave of price rise tide.

Vitamin, March 25, VD3 quoted US$ 35.25 /kg, compared to the beginning of the year (January 20, 2020) increase 170%;VB1 quoted US$42 yuan/kg, up 90% from the beginning of the year; Biotin quoted US$43 /kg, up 74% from the beginning of the year; The quotation of VA is US$71.2 /kg, which is 64% higher than that of the beginning of the year. Vitamin K3 quoted US$13 /kg, 59% higher than the beginning of the year;VE quoted US$10.22/kg, up 49% from the beginning of the year.

In terms of antibiotics, under the influence of the epidemic, the supply side is gradually tight, and the price of major varieties has also shown a trend of increasing, especially the intermediate varieties with oligopoly pattern, such as 6-apa, whose market price recently increased from 20.0 US$ to 28.7 US$ per kg.

 

Global Specialty Active Pharmaceutical Ingredients Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

 

Global Specialty Active Pharmaceutical Ingredients Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

Global Specialty Active Pharmaceutical Ingredients Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

 

Global Specialty Active Pharmaceutical Ingredients Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

 

Following are the segments covered by the report are:

  • Steroidal API
  • Peptide API
  • Carbohydrate API
  • Small Molecule API
  • High Potency AP

 

By Application:

  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

 

The Key manufacturers that are operating in the global Specialty Active Pharmaceutical Ingredients market are:

  • Sanofi
  • Cambrex
  • Almac
  • Johnson Matthey
  • PolyPeptide
  • AmbioPharm
  • Avecia
  • ST Pharm
  • Biospring

 
Competitive Landscape

The analysts have provided a comprehensive analysis of the competitive landscape of the global Specialty Active Pharmaceutical Ingredients market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

TABLE OF CONTENT:

 

1 Specialty Active Pharmaceutical Ingredients Market Overview

1.1 Product Overview and Scope of Specialty Active Pharmaceutical Ingredients

1.2 Specialty Active Pharmaceutical Ingredients Segment by Type

1.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Steroidal API

1.2.3 Peptide API

1.2.4 Carbohydrate API

1.2.5 Small Molecule API

1.2.6 High Potency AP

1.3 Specialty Active Pharmaceutical Ingredients Segment by Application

1.3.1 Specialty Active Pharmaceutical Ingredients Sales Comparison by Application: 2020 VS 2026

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Genitourinary/Hormonal Drugs

1.3.5 Rheumatology

1.3.6 Diabetes

1.3.7 Oncology

1.3.8 Others

1.4 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts

1.4.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026

1.4.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026

1.4.3 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026

 

2 Global Specialty Active Pharmaceutical Ingredients Market Competition by Manufacturers

2.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)

2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)

2.3 Global Specialty Active Pharmaceutical Ingredients Average Price by Manufacturers (2015-2020)

2.4 Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites, Area Served, Product Type

2.5 Specialty Active Pharmaceutical Ingredients Market Competitive Situation and Trends

2.5.1 Specialty Active Pharmaceutical Ingredients Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)

 

3 Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario by Region

3.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.3.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country

3.3.2 North America Specialty Active Pharmaceutical Ingredients Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.4.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country

3.4.2 Europe Specialty Active Pharmaceutical Ingredients Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Region

3.5.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region

3.5.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.6.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country

3.6.2 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.7.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country

3.7.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

 

4 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Type

4.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)

4.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)

4.3 Global Specialty Active Pharmaceutical Ingredients Price Market Share by Type (2015-2020)

4.4 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

 

5 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Application

5.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

5.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)

5.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)

 

6 Company Profiles and Key Figures in Specialty Active Pharmaceutical Ingredients Business

6.1 Sanofi

6.1.1 Corporation Information

6.1.2 Sanofi Description, Business Overview and Total Revenue

6.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Sanofi Products Offered

6.1.5 Sanofi Recent Development

6.2 Cambrex

6.2.1 Cambrex Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.2.2 Cambrex Description, Business Overview and Total Revenue

6.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.2.4 Cambrex Products Offered

6.2.5 Cambrex Recent Development

6.3 Almac

6.3.1 Almac Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.3.2 Almac Description, Business Overview and Total Revenue

6.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.3.4 Almac Products Offered

6.3.5 Almac Recent Development

6.4 Johnson Matthey

6.4.1 Johnson Matthey Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.4.2 Johnson Matthey Description, Business Overview and Total Revenue

6.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Johnson Matthey Products Offered

6.4.5 Johnson Matthey Recent Development

6.5 PolyPeptide

6.5.1 PolyPeptide Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.5.2 PolyPeptide Description, Business Overview and Total Revenue

6.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.5.4 PolyPeptide Products Offered

6.5.5 PolyPeptide Recent Development

6.6 AmbioPharm

6.6.1 AmbioPharm Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.6.2 AmbioPharm Description, Business Overview and Total Revenue

6.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.6.4 AmbioPharm Products Offered

6.6.5 AmbioPharm Recent Development

6.7 Avecia

6.6.1 Avecia Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.6.2 Avecia Description, Business Overview and Total Revenue

6.6.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Avecia Products Offered

6.7.5 Avecia Recent Development

6.8 ST Pharm

6.8.1 ST Pharm Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.8.2 ST Pharm Description, Business Overview and Total Revenue

6.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.8.4 ST Pharm Products Offered

6.8.5 ST Pharm Recent Development

6.9 Biospring

6.9.1 Biospring Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.9.2 Biospring Description, Business Overview and Total Revenue

6.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.9.4 Biospring Products Offered

6.9.5 Biospring Recent Development

 

7 Specialty Active Pharmaceutical Ingredients Manufacturing Cost Analysis

7.1 Specialty Active Pharmaceutical Ingredients Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients

7.4 Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis

 

8 Marketing Channel, Distributors, and Customers

8.1 Marketing Channel

8.2 Specialty Active Pharmaceutical Ingredients Distributors List

8.3 Specialty Active Pharmaceutical Ingredients Customers

 

9 Market Dynamics

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

 

10 Global Market Forecast

10.1 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)

10.1.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)

10.2 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)

10.2.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)

10.3 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)

10.3.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)

10.4 North America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.5 Europe Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.6 Asia Pacific Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.7 Latin America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.8 Middle East and Africa Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

 

11 Research Finding and Conclusion

 

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer"

LIST OF TABLES OF FIGURES :

 

Table 1. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Comparison by Application: 2020 VS 2026

Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size by Type (K MT) (US$ Million) (2020 VS 2026)

Table 4. Global Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered in This Study

Table 5. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Manufacturers (2015-2020)

Table 6. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)

Table 7. Global Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Specialty Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Specialty Active Pharmaceutical Ingredients Sales Sites and Area Served

Table 11. Manufacturers Specialty Active Pharmaceutical Ingredients Product Types

Table 12. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)

Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players

Table 16. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Region (2015-2020)

Table 17. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Table 18. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Region (2015-2020)

Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Table 20. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 21. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 22. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 24. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 25. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 26. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)

Table 29. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Table 32. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 33. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 34. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 37. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 40. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)

Table 41. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)

Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Type (2015-2020)

Table 43. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)

Table 44. Global Specialty Active Pharmaceutical Ingredients Price (USD/MT) by Type (2015-2020)

Table 45. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)

Table 46. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

Table 47. Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate by Application (2015-2020)

Table 48. Sanofi Specialty Active Pharmaceutical Ingredients Corporation Information

Table 49. Sanofi Description and Business Overview

Table 50. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 51. Sanofi Main Product

Table 52. Sanofi Recent Development

Table 53. Cambrex Specialty Active Pharmaceutical Ingredients Corporation Information

Table 54. Cambrex Corporation Information

Table 55. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 56. Cambrex Main Product

Table 57. Cambrex Recent Development

Table 58. Almac Specialty Active Pharmaceutical Ingredients Corporation Information

Table 59. Almac Corporation Information

Table 60. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 61. Almac Main Product

Table 62. Almac Recent Development

Table 63. Johnson Matthey Specialty Active Pharmaceutical Ingredients Corporation Information

Table 64. Johnson Matthey Corporation Information

Table 65. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 66. Johnson Matthey Main Product

Table 67. Johnson Matthey Recent Development

Table 68. PolyPeptide Specialty Active Pharmaceutical Ingredients Corporation Information

Table 69. PolyPeptide Corporation Information

Table 70. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 71. PolyPeptide Main Product

Table 72. PolyPeptide Recent Development

Table 73. AmbioPharm Specialty Active Pharmaceutical Ingredients Corporation Information

Table 74. AmbioPharm Corporation Information

Table 75. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 76. AmbioPharm Main Product

Table 77. AmbioPharm Recent Development

Table 78. Avecia Specialty Active Pharmaceutical Ingredients Corporation Information

Table 79. Avecia Corporation Information

Table 80. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 81. Avecia Main Product

Table 82. Avecia Recent Development

Table 83. ST Pharm Specialty Active Pharmaceutical Ingredients Corporation Information

Table 84. ST Pharm Corporation Information

Table 85. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 86. ST Pharm Main Product

Table 87. ST Pharm Recent Development

Table 88. Biospring Specialty Active Pharmaceutical Ingredients Corporation Information

Table 89. Biospring Corporation Information

Table 90. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 91. Biospring Main Product

Table 92. Biospring Recent Development

Table 93. Sales Base and Market Concentration Rate of Raw Material

Table 94. Key Suppliers of Raw Materials

Table 95. Specialty Active Pharmaceutical Ingredients Distributors List

Table 96. Specialty Active Pharmaceutical Ingredients Customers List

Table 97. Market Key Trends

Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 99. Key Challenges

Table 100. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Type (2021-2026)

Table 101. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2021-2026)

Table 102. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Type (2021-2026)

Table 103. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 104. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Application (2021-2026)

Table 105. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Application (2021-2026)

Table 106. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Region (2021-2026)

Table 107. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2021-2026)

Table 108. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)

Table 109. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2021-2026)

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Specialty Active Pharmaceutical Ingredients

Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type: 2020 VS 2026

Figure 3. Steroidal API Product Picture

Figure 4. Peptide API Product Picture

Figure 5. Carbohydrate API Product Picture

Figure 6. Small Molecule API Product Picture

Figure 7. High Potency AP Product Picture

Figure 8. Global Specialty Active Pharmaceutical Ingredients Consumption Market Share by Application: 2020 VS 2026

Figure 9. CNS

Figure 10. Cardiovascular

Figure 11. Genitourinary/Hormonal Drugs

Figure 12. Rheumatology

Figure 13. Diabetes

Figure 14. Oncology

Figure 15. Others

Figure 16. Global Specialty Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)

Figure 17. Global Specialty Active Pharmaceutical Ingredients Sales Capacity (K MT) (2015-2026)

Figure 18. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026

Figure 19. Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers in 2020

Figure 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers in 2019

Figure 21. The Global 5 and 10 Largest Players: Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2019

Figure 22. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 23. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019

Figure 25. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Figure 26. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019

Figure 27. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 28. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 29. U.S. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 30. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 31. Canada Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 32. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 33. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 34. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 35. Germany Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 36. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 37. France Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 38. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. U.K. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 40. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 41. Italy Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 42. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 43. Russia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 44. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019

Figure 46. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019

Figure 47. China Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 48. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. Japan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 50. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. South Korea Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 52. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. India Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 54. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Australia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 56. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Taiwan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 58. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Indonesia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 60. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Thailand Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 62. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Malaysia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 64. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Philippines Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 66. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Vietnam Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 68. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 70. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 71. Mexico Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 72. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Brazil Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 74. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Argentina Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 76. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 78. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 79. Turkey Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 80. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Saudi Arabia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 82. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. U.A.E Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 84. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)

Figure 86. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019

Figure 87. Revenue Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)

Figure 88. Revenue Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019

Figure 89. Global Specialty Active Pharmaceutical Ingredients Sales Growth by Type (2015-2020) (K MT)

Figure 90. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

Figure 91. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019

Figure 92. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application (2015-2020)

Figure 93. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application in 2020

Figure 94. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Almac Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Avecia Total Revenue (US$ Million): 2019 Compared with 2018

Figure 101. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 102. Biospring Total Revenue (US$ Million): 2019 Compared with 2018

Figure 103. Price Trend of Key Raw Materials

Figure 104. Manufacturing Cost Structure of Specialty Active Pharmaceutical Ingredients

Figure 105. Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients

Figure 106. Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis

Figure 107. Channels of Distribution

Figure 108. Distributors Profiles

Figure 109. Porter's Five Forces Analysis

Figure 110. North America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 111. North America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 112. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 113. Europe Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 114. Latin America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 115. Latin America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 116. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 117. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 118. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 119. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 120. Bottom-up and Top-down Approaches for This Report

Figure 121. Data Triangulation

Figure 122. Key Executives Interviewed"

SPECIALTY ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET OVERVIEW:

 

Active Pharmaceutical Ingredients (API) is a key link in pharmaceutical production and closely related to public health. And the Special API is different from the bulk API, has the characteristics of strong growth attribute, high customer stickiness, non-standard and so on, usually the gross profit rate and the net profit rate are high. Once the enterprise occupies a higher share in the dominant variety market, it can enjoy long-term stable profits.

Special APIs are components of chemical APIs. Chemical API companies generally produce and sell products independently or according to the needs of downstream customers.Its market is large and its customers are usually pharmaceutical preparation manufacturers, health products manufacturers, feed manufacturers and food manufacturers.

Featured API usually refers to the drug under patent protection or the drug under patent protection. If the enterprise can in innovative drug development stage and the original drug firms through customization methods such as establish relations of cooperation, to provide the clinical trials needed for active pharmaceutical ingredients, then after the product, the enterprise can to provide the original manufacturer pharmaceutical intermediates or APIs, usually can get stable orders, lasting profits for the enterprise. For drugs that have passed the patent period, take the export to the us market as an example, the API manufacturers usually pass the FDA certification before the patent drug expires, apply for the DMF filing, and carry out production capacity reserve. The customers also inform the API manufacturers to prepare the products in time. Generally, after the expiration of patented drugs, a large number of generic drugs will come to market, and drug prices will fall, which will increase the sales volume of generic drugs, and thus drive the demand for API drugs.

The main levels of Statins API are divided into Statins API, Heparin API and others such as Sartans API according to different fields.

Statins, with their high efficiency, safety and tolerability in lowering LDL and cholesterol, are in an unassailable position compared with other lipid-lowering drugs such as niacin and betts, with a market share of up to 90%.

Heparin API is in the middle of the heparin industry chain.First, the crude heparin sodium was extracted from the small intestinal mucosa of healthy pigs and made into heparin. Due to the impurities such as miscellaneous proteins, it was further purified and turned into heparin API.Heparin APIs are commonly found in the form of Sodium or Calcium salts, known as Heparin Sodium or Heparin Calcium, and are used in excess of standard Heparin Sodium.

 

The major Statins APIs player in the market

  • Livzon Pharmaceutical Group
  • Zhejiang Medicine
  • Zhejiang Hisun Pharmaceutical
  • Chongqing Daxin Pharmaceutical
  • Jiangsu Guotai International Group

 

In addition to the mainstream Statins APIs of various manufacturers, each manufacturer also has different models and functions of Heparin API

The major Heparin API player in the market

  • Changzhou Qianhong Biopharmal
  • Shenzhen Hepalink Pharmaceutical Group
  • CSBIO
  • Nanjing King-friend Biochemical Pharmaceutical

Heparin API belongs to Special API (different from bulk API). Heparin APIs are mainly used in the production of standard heparin preparations or low molecular weight heparin APIs, which can be further used in the production of low molecular weight heparin preparations.

In addition to the companies listed in the above table, Huahai Pharmaceutical, Apeloa Pharmaceutical, Borui Medicine, Jiuzhou Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Xianju Pharmaceutical, Zhejiang Starry Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Ausun Pharmaceutical, Jiangxi Synergy Pharmaceutical, Jiangxi Fushine Pharmaceutical, developed and manufacture Statins API.

According to the statistics of the medical insurance chamber of commerce, in 2018, China exported 929.72 tons of western medicine API (synthesis + fermentation), with a total export value of us $30.048 billion, accounting for about 19% of the global API market. outlines the location of manufacturing facilities used to make APIs for US-marketed drugs. For all regulated drugs (prescription [branded and generics], OTC products, and compounded drugs, the US has 510 manufacturing facilities or 28%, the rest of the world (non-China) 1,048 facilities, or 59%, and China 230 facilities or 13%.

 Specialty Active Pharmaceutical Ingredients (API ) Manufacturing

With the optimization of statin API production process and the formation of industrial scale in China, the capacity and output of statin API have been objectively promoted. With COVID-19 spreading globally, Europe and the United States have suffered a major impact. Meanwhile, COVID-19 affect major API suppliers such as India, China and Japan.

On March 24, India announced the start of a nationwide lockdown for 21 days as a precaution against COVID 19. But when India announced its decision, the global drug industry was not calm - after all, India is the world's largest producer of generic drugs, the 13th largest exporter by value and the third largest exporter by volume, which is crucial to the world's drug supply.

Global Special API Market Share

Under the influence of the global COVID 19 epidemic, China's API products ushered in a wave of price rise tide.

Vitamin, March 25, VD3 quoted US$ 35.25 /kg, compared to the beginning of the year (January 20, 2020) increase 170%;VB1 quoted US$42 yuan/kg, up 90% from the beginning of the year; Biotin quoted US$43 /kg, up 74% from the beginning of the year; The quotation of VA is US$71.2 /kg, which is 64% higher than that of the beginning of the year. Vitamin K3 quoted US$13 /kg, 59% higher than the beginning of the year;VE quoted US$10.22/kg, up 49% from the beginning of the year.

In terms of antibiotics, under the influence of the epidemic, the supply side is gradually tight, and the price of major varieties has also shown a trend of increasing, especially the intermediate varieties with oligopoly pattern, such as 6-apa, whose market price recently increased from 20.0 US$ to 28.7 US$ per kg.

 

Global Specialty Active Pharmaceutical Ingredients Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

 

Global Specialty Active Pharmaceutical Ingredients Market: Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

Global Specialty Active Pharmaceutical Ingredients Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

 

Global Specialty Active Pharmaceutical Ingredients Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

 

Following are the segments covered by the report are:

  • Steroidal API
  • Peptide API
  • Carbohydrate API
  • Small Molecule API
  • High Potency AP

 

By Application:

  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

 

The Key manufacturers that are operating in the global Specialty Active Pharmaceutical Ingredients market are:

  • Sanofi
  • Cambrex
  • Almac
  • Johnson Matthey
  • PolyPeptide
  • AmbioPharm
  • Avecia
  • ST Pharm
  • Biospring

 
Competitive Landscape

The analysts have provided a comprehensive analysis of the competitive landscape of the global Specialty Active Pharmaceutical Ingredients market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

Read More
TABLE OF CONTENT:

 

1 Specialty Active Pharmaceutical Ingredients Market Overview

1.1 Product Overview and Scope of Specialty Active Pharmaceutical Ingredients

1.2 Specialty Active Pharmaceutical Ingredients Segment by Type

1.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Steroidal API

1.2.3 Peptide API

1.2.4 Carbohydrate API

1.2.5 Small Molecule API

1.2.6 High Potency AP

1.3 Specialty Active Pharmaceutical Ingredients Segment by Application

1.3.1 Specialty Active Pharmaceutical Ingredients Sales Comparison by Application: 2020 VS 2026

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Genitourinary/Hormonal Drugs

1.3.5 Rheumatology

1.3.6 Diabetes

1.3.7 Oncology

1.3.8 Others

1.4 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts

1.4.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026

1.4.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026

1.4.3 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026

 

2 Global Specialty Active Pharmaceutical Ingredients Market Competition by Manufacturers

2.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)

2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)

2.3 Global Specialty Active Pharmaceutical Ingredients Average Price by Manufacturers (2015-2020)

2.4 Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites, Area Served, Product Type

2.5 Specialty Active Pharmaceutical Ingredients Market Competitive Situation and Trends

2.5.1 Specialty Active Pharmaceutical Ingredients Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)

 

3 Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario by Region

3.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.3.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country

3.3.2 North America Specialty Active Pharmaceutical Ingredients Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.4.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country

3.4.2 Europe Specialty Active Pharmaceutical Ingredients Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Region

3.5.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region

3.5.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.6.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country

3.6.2 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Country

3.7.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country

3.7.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

 

4 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Type

4.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)

4.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)

4.3 Global Specialty Active Pharmaceutical Ingredients Price Market Share by Type (2015-2020)

4.4 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

 

5 Global Specialty Active Pharmaceutical Ingredients Historic Market Analysis by Application

5.1 Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

5.2 Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)

5.3 Global Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)

 

6 Company Profiles and Key Figures in Specialty Active Pharmaceutical Ingredients Business

6.1 Sanofi

6.1.1 Corporation Information

6.1.2 Sanofi Description, Business Overview and Total Revenue

6.1.3 Sanofi Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Sanofi Products Offered

6.1.5 Sanofi Recent Development

6.2 Cambrex

6.2.1 Cambrex Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.2.2 Cambrex Description, Business Overview and Total Revenue

6.2.3 Cambrex Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.2.4 Cambrex Products Offered

6.2.5 Cambrex Recent Development

6.3 Almac

6.3.1 Almac Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.3.2 Almac Description, Business Overview and Total Revenue

6.3.3 Almac Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.3.4 Almac Products Offered

6.3.5 Almac Recent Development

6.4 Johnson Matthey

6.4.1 Johnson Matthey Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.4.2 Johnson Matthey Description, Business Overview and Total Revenue

6.4.3 Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Johnson Matthey Products Offered

6.4.5 Johnson Matthey Recent Development

6.5 PolyPeptide

6.5.1 PolyPeptide Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.5.2 PolyPeptide Description, Business Overview and Total Revenue

6.5.3 PolyPeptide Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.5.4 PolyPeptide Products Offered

6.5.5 PolyPeptide Recent Development

6.6 AmbioPharm

6.6.1 AmbioPharm Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.6.2 AmbioPharm Description, Business Overview and Total Revenue

6.6.3 AmbioPharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.6.4 AmbioPharm Products Offered

6.6.5 AmbioPharm Recent Development

6.7 Avecia

6.6.1 Avecia Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.6.2 Avecia Description, Business Overview and Total Revenue

6.6.3 Avecia Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Avecia Products Offered

6.7.5 Avecia Recent Development

6.8 ST Pharm

6.8.1 ST Pharm Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.8.2 ST Pharm Description, Business Overview and Total Revenue

6.8.3 ST Pharm Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.8.4 ST Pharm Products Offered

6.8.5 ST Pharm Recent Development

6.9 Biospring

6.9.1 Biospring Specialty Active Pharmaceutical Ingredients Production Sites and Area Served

6.9.2 Biospring Description, Business Overview and Total Revenue

6.9.3 Biospring Specialty Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2015-2020)

6.9.4 Biospring Products Offered

6.9.5 Biospring Recent Development

 

7 Specialty Active Pharmaceutical Ingredients Manufacturing Cost Analysis

7.1 Specialty Active Pharmaceutical Ingredients Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients

7.4 Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis

 

8 Marketing Channel, Distributors, and Customers

8.1 Marketing Channel

8.2 Specialty Active Pharmaceutical Ingredients Distributors List

8.3 Specialty Active Pharmaceutical Ingredients Customers

 

9 Market Dynamics

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

 

10 Global Market Forecast

10.1 Global Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)

10.1.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Type (2021-2026)

10.2 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)

10.2.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Application (2021-2026)

10.3 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)

10.3.2 Global Forecasted Revenue of Specialty Active Pharmaceutical Ingredients by Region (2021-2026)

10.4 North America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.5 Europe Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.6 Asia Pacific Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.7 Latin America Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

10.8 Middle East and Africa Specialty Active Pharmaceutical Ingredients Estimates and Projections (2021-2026)

 

11 Research Finding and Conclusion

 

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer"

Read More
LIST OF TABLES OF FIGURES :

 

Table 1. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Comparison by Application: 2020 VS 2026

Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size by Type (K MT) (US$ Million) (2020 VS 2026)

Table 4. Global Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered in This Study

Table 5. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Manufacturers (2015-2020)

Table 6. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)

Table 7. Global Specialty Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Specialty Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Specialty Active Pharmaceutical Ingredients Sales Sites and Area Served

Table 11. Manufacturers Specialty Active Pharmaceutical Ingredients Product Types

Table 12. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)

Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players

Table 16. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Region (2015-2020)

Table 17. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Table 18. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Region (2015-2020)

Table 19. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Table 20. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 21. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 22. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 24. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 25. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 26. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)

Table 29. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Table 32. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 33. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 34. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)

Table 37. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)

Table 40. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2015-2020)

Table 41. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)

Table 42. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Type (2015-2020)

Table 43. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)

Table 44. Global Specialty Active Pharmaceutical Ingredients Price (USD/MT) by Type (2015-2020)

Table 45. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2015-2020)

Table 46. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

Table 47. Global Specialty Active Pharmaceutical Ingredients Sales Growth Rate by Application (2015-2020)

Table 48. Sanofi Specialty Active Pharmaceutical Ingredients Corporation Information

Table 49. Sanofi Description and Business Overview

Table 50. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 51. Sanofi Main Product

Table 52. Sanofi Recent Development

Table 53. Cambrex Specialty Active Pharmaceutical Ingredients Corporation Information

Table 54. Cambrex Corporation Information

Table 55. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 56. Cambrex Main Product

Table 57. Cambrex Recent Development

Table 58. Almac Specialty Active Pharmaceutical Ingredients Corporation Information

Table 59. Almac Corporation Information

Table 60. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 61. Almac Main Product

Table 62. Almac Recent Development

Table 63. Johnson Matthey Specialty Active Pharmaceutical Ingredients Corporation Information

Table 64. Johnson Matthey Corporation Information

Table 65. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 66. Johnson Matthey Main Product

Table 67. Johnson Matthey Recent Development

Table 68. PolyPeptide Specialty Active Pharmaceutical Ingredients Corporation Information

Table 69. PolyPeptide Corporation Information

Table 70. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 71. PolyPeptide Main Product

Table 72. PolyPeptide Recent Development

Table 73. AmbioPharm Specialty Active Pharmaceutical Ingredients Corporation Information

Table 74. AmbioPharm Corporation Information

Table 75. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 76. AmbioPharm Main Product

Table 77. AmbioPharm Recent Development

Table 78. Avecia Specialty Active Pharmaceutical Ingredients Corporation Information

Table 79. Avecia Corporation Information

Table 80. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 81. Avecia Main Product

Table 82. Avecia Recent Development

Table 83. ST Pharm Specialty Active Pharmaceutical Ingredients Corporation Information

Table 84. ST Pharm Corporation Information

Table 85. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 86. ST Pharm Main Product

Table 87. ST Pharm Recent Development

Table 88. Biospring Specialty Active Pharmaceutical Ingredients Corporation Information

Table 89. Biospring Corporation Information

Table 90. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

Table 91. Biospring Main Product

Table 92. Biospring Recent Development

Table 93. Sales Base and Market Concentration Rate of Raw Material

Table 94. Key Suppliers of Raw Materials

Table 95. Specialty Active Pharmaceutical Ingredients Distributors List

Table 96. Specialty Active Pharmaceutical Ingredients Customers List

Table 97. Market Key Trends

Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 99. Key Challenges

Table 100. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Type (2021-2026)

Table 101. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2021-2026)

Table 102. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Type (2021-2026)

Table 103. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 104. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Application (2021-2026)

Table 105. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) Forecast by Application (2021-2026)

Table 106. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Forecast by Region (2021-2026)

Table 107. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2021-2026)

Table 108. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)

Table 109. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2021-2026)

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Specialty Active Pharmaceutical Ingredients

Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type: 2020 VS 2026

Figure 3. Steroidal API Product Picture

Figure 4. Peptide API Product Picture

Figure 5. Carbohydrate API Product Picture

Figure 6. Small Molecule API Product Picture

Figure 7. High Potency AP Product Picture

Figure 8. Global Specialty Active Pharmaceutical Ingredients Consumption Market Share by Application: 2020 VS 2026

Figure 9. CNS

Figure 10. Cardiovascular

Figure 11. Genitourinary/Hormonal Drugs

Figure 12. Rheumatology

Figure 13. Diabetes

Figure 14. Oncology

Figure 15. Others

Figure 16. Global Specialty Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)

Figure 17. Global Specialty Active Pharmaceutical Ingredients Sales Capacity (K MT) (2015-2026)

Figure 18. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026

Figure 19. Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers in 2020

Figure 20. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers in 2019

Figure 21. The Global 5 and 10 Largest Players: Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2019

Figure 22. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 23. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)

Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019

Figure 25. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)

Figure 26. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019

Figure 27. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 28. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 29. U.S. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 30. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 31. Canada Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 32. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 33. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 34. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 35. Germany Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 36. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 37. France Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 38. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. U.K. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 40. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 41. Italy Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 42. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 43. Russia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 44. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019

Figure 46. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019

Figure 47. China Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 48. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. Japan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 50. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. South Korea Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 52. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. India Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 54. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Australia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 56. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Taiwan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 58. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Indonesia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 60. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Thailand Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 62. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Malaysia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 64. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Philippines Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 66. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Vietnam Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 68. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 70. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 71. Mexico Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 72. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Brazil Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 74. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Argentina Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 76. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019

Figure 78. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019

Figure 79. Turkey Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 80. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Saudi Arabia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 82. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. U.A.E Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)

Figure 84. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)

Figure 86. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019

Figure 87. Revenue Share of Specialty Active Pharmaceutical Ingredients by Type (2015-2020)

Figure 88. Revenue Market Share of Specialty Active Pharmaceutical Ingredients by Type in 2019

Figure 89. Global Specialty Active Pharmaceutical Ingredients Sales Growth by Type (2015-2020) (K MT)

Figure 90. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)

Figure 91. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019

Figure 92. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application (2015-2020)

Figure 93. Global Revenue Share of Specialty Active Pharmaceutical Ingredients by Application in 2020

Figure 94. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Almac Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Avecia Total Revenue (US$ Million): 2019 Compared with 2018

Figure 101. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 102. Biospring Total Revenue (US$ Million): 2019 Compared with 2018

Figure 103. Price Trend of Key Raw Materials

Figure 104. Manufacturing Cost Structure of Specialty Active Pharmaceutical Ingredients

Figure 105. Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients

Figure 106. Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis

Figure 107. Channels of Distribution

Figure 108. Distributors Profiles

Figure 109. Porter's Five Forces Analysis

Figure 110. North America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 111. North America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 112. Europe Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 113. Europe Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 114. Latin America Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 115. Latin America Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 116. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 117. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 118. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate Forecast (2021-2026)

Figure 119. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 120. Bottom-up and Top-down Approaches for This Report

Figure 121. Data Triangulation

Figure 122. Key Executives Interviewed"

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$4350
This license allows multiple user to access the PDF.

Enterprise License

Electronic (PDF)
$5800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Covid 19 Impact on Acute Lymphoblastic Leukemia Market Global Research Reports 2020 2021
Covid-19 Impact on Acute Lymphoblastic Leukemia Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-1E2997
Tue May 19 00:00:00 UTC 2020

Add to Cart

Covid 19 Impact on Elspar Market Global Research Reports 2020 2021
Covid-19 Impact on Elspar Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-37Z2522
Tue May 19 00:00:00 UTC 2020

Add to Cart

Covid 19 Impact on Companion Diagnostic Technologies Market Global Research Reports 2020 2021
Covid-19 Impact on Companion Diagnostic Technologies Market, Global Research Reports 2020-2021

120 Pages
Type: Report
Code: QYRE-Auto-31X2542
Tue May 19 00:00:00 UTC 2020

Add to Cart

Covid 19 Impact on Global Viral Vector Manufacturing Market Size Status and Forecast 2020 2026
Covid-19 Impact on Global Viral Vector Manufacturing Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-13J2823
Tue May 19 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0